Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Baton Rouge › NPI 1962537407
Hospital

Baton Rouge General Medical Center

Baton Rouge General Medical Center was paid $24.31M by Medicaid between Jan 2018 and Dec 2024, across 207 billing codes. Its largest line is 99285, emergency room visit (most serious) — 26% of everything it billed.

33Billing provider infoBATON ROUGE GENERAL MEDICAL CENTER
BATON ROUGE, LA 70809
33aNPI1962537407assigned 02/23/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$24.31M
24GClaims810,212
24DCodes billed207
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#20 of 96
Median peer was paid$5.17M
This provider vs. median4.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201859,776$1.89M
201968,177$2.26M
202064,621$1.94M
2021113,405$3.80M
2022160,068$5.25M
2023223,729$5.99M
2024incomplete120,436$3.19M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 26% 34,706 30,409 $6.39M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.6% 25,484 23,089 $2.10M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.9% 15,735 14,260 $1.92M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 7.7% 11,998 4,366 $1.88M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 3.4% 29,183 22,357 $815K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 3.3% 29,198 22,346 $810K
16020 2.6% 3,168 1,651 $638K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.5% 9,453 8,709 $601K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.4% 20,946 18,435 $580K
80053 Comprehensive metabolic panel 2.3% 81,315 69,653 $568K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.9% 19,058 15,102 $456K
87536 1.8% 7,060 5,732 $450K
195 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.6% 19,386 $395K
11043 1.6% 3,365 $388K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.5% 76,750 $377K
80050 General health panel 1.4% 9,734 $339K
96361 Intravenous infusion, hydration; each additional hour 1.4% 11,608 $330K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.3% 790 $314K
19318 1.3% 704 $306K
80061 Lipid panel 1.3% 29,377 $305K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.2% 16,490 $297K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.1% 12,559 $259K
71045 Radiologic examination, chest; single view <1% 10,221 $228K
70450 Computed tomography, head or brain; without contrast material <1% 1,586 $214K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 11,943 $183K
83036 Hemoglobin; glycosylated (A1C) <1% 24,432 $180K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 4,847 $180K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 6,277 $167K
80074 <1% 4,164 $129K
86361 <1% 5,970 $125K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,543 $114K
71046 Radiologic examination, chest; 2 views <1% 3,746 $110K
84703 <1% 17,548 $97K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 365 $94K
84443 Thyroid stimulating hormone (TSH) <1% 7,317 $89K
84484 <1% 13,274 $83K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 685 $79K
96375 Therapeutic injection; each additional sequential IV push <1% 3,314 $77K
86480 <1% 1,473 $71K
78264 <1% 345 $68K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 1,918 $66K
81001 <1% 28,472 $60K
81513 <1% 1,016 $57K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 582 $56K
86592 <1% 16,242 $55K
86803 <1% 5,418 $54K
86708 <1% 5,675 $54K
87522 Neg quan hep c or qual rna <1% 1,560 $53K
87481 <1% 2,197 $52K
76981 <1% 386 $47K
87400 <1% 3,731 $45K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 573 $39K
83690 <1% 8,711 $38K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 771 $35K
77067 Screening mammography, bilateral, including computer-aided detection <1% 707 $34K
86706 <1% 4,028 $34K
86780 <1% 3,852 $34K
85730 <1% 10,126 $31K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 735 $31K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 258 $30K
36415 Collection of venous blood by venipuncture <1% 16,258 $30K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,599 $29K
85610 <1% 12,042 $27K
99213 Doctor's office visit, returning patient (routine) <1% 1,808 $26K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 692 $22K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,141 $22K
86317 <1% 1,396 $22K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,307 $20K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,851 $19K
J7030 Infusion, normal saline solution , 1000 cc <1% 6,626 $18K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 248 $17K
G0378 Hospital observation service, per hour <1% 263 $16K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 607 $16K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,473 $14K
83605 <1% 2,152 $13K
17111 <1% 19 $12K
86704 <1% 1,347 $12K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 405 $12K
80048 Basic metabolic panel (calcium, ionized) <1% 1,837 $12K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 57 $11K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,336 $11K
17110 <1% 13 $10K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 88 $10K
74246 <1% 100 $10K
81003 <1% 5,955 $10K
84153 <1% 717 $9K
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries <1% 360 $8K
83735 <1% 2,336 $8K
84439 <1% 1,096 $8K
83880 <1% 456 $8K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,429 $7K
86705 <1% 786 $7K
87430 <1% 461 $5K
76830 Ultrasound, transvaginal <1% 52 $5K
99204 Doctor's office visit, new patient (more involved) <1% 879 $5K
82043 <1% 1,068 $5K
86593 <1% 1,558 $5K
85027 <1% 846 $5K
84403 <1% 207 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 96 $4K
82607 <1% 421 $4K
82728 <1% 432 $4K
82570 <1% 828 $3K
83540 <1% 748 $3K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 238 $3K
78227 <1% 14 $3K
80081 <1% 39 $3K
83550 <1% 453 $3K
99214 Doctor's office visit, returning patient (more involved) <1% 107 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 14 $3K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 13 $2K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 53 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 52 $2K
80076 <1% 249 $2K
87653 <1% 81 $2K
J7050 Infusion, normal saline solution, 250 cc <1% 561 $2K
87081 <1% 399 $2K
86140 <1% 877 $2K
A4467 Belt, strap, sleeve, garment, or covering, any type <1% 17 $2K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 38 $2K
87340 <1% 160 $1K
83013 <1% 50 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 829 $1K
84154 <1% 79 $1K
C1769 Guide wire <1% 40 $1K
72100 <1% 31 $1K
84481 <1% 104 $1K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 49 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 112 $1K
J2704 Injection, propofol, 10 mg <1% 2,503 $1K
86645 <1% 72 $1K
86376 <1% 76 $990.12
86777 <1% 87 $952.05
82746 <1% 105 $911.40
29581 <1% 32 $905.48
84702 <1% 66 $879.09
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 68 $873.10
73564 <1% 14 $857.58
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 125 $823.10
84134 <1% 569 $796.77
29445 <1% 35 $755.99
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,380 $649.75
88112 <1% 13 $630.52
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 628 $613.67
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 79 $543.95
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,938 $531.69
82950 <1% 127 $518.89
84480 <1% 64 $461.73
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 44 $461.22
11045 <1% 2,341 $453.45
87077 <1% 307 $444.73
87186 <1% 307 $423.85
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,302 $422.00
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 12 $388.71
82150 <1% 56 $384.23
86850 <1% 95 $377.44
82550 <1% 104 $341.43
99152 <1% 52 $339.11
86644 <1% 29 $316.58
83525 <1% 38 $274.32
84460 <1% 68 $270.50
83516 <1% 15 $265.37
84450 <1% 68 $264.37
80055 <1% 19 $250.32
85652 <1% 539 $239.22
87070 <1% 771 $224.12
83001 <1% 22 $223.76
82164 <1% 14 $212.25
82747 <1% 19 $211.80
87075 <1% 739 $208.34
82103 <1% 14 $195.32
86901 <1% 105 $194.35
86900 <1% 106 $194.35
82077 <1% 27 $181.31
82390 <1% 14 $156.13
J0690 Injection, cefazolin sodium, 500 mg <1% 1,098 $155.95
83020 <1% 12 $154.44
87420 <1% 12 $153.01
99153 Mod sedat endo service >5yrs <1% 26 $152.28
77063 Screening digital breast tomosynthesis, bilateral <1% 13 $144.80
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 14 $129.28
86702 <1% 17 $128.70
J1170 Injection, hydromorphone, up to 4 mg <1% 418 $128.03
84100 <1% 37 $92.52
87205 <1% 749 $89.67
86701 <1% 17 $88.90
85045 <1% 49 $87.78
85660 <1% 15 $86.52
81025 <1% 404 $81.50
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 107 $77.68
87176 <1% 629 $70.56
87210 <1% 14 $66.03
J3490 Unclassified drugs <1% 1,797 $65.89
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 825 $60.31
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 30 $59.31
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 754 $50.34
J1644 Injection, heparin sodium, per 1000 units <1% 272 $44.84
82947 <1% 15 $39.30
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 312 $36.85
99201 <1% 30 $21.84
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 15 $12.32
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 32 $12.09
85014 <1% 26 $11.85
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 382 $2.94
A9270 Non-covered item or service 0% 366 $0.00
11046 0% 270 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 117 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVIATOR, DIONNE (SR VP AND CFO)
Same official

Other billing entities under VIATOR, DIONNE

Full network →
ProviderLocationPaid
Iberia Medical Center Physician Practice NetworkNew Iberia, LA$1.79M
Hospital Service District No. 1 of Iberia ParishJeanerette, LA$1.45M
Hospital Service District No. 1 of Iberia ParishNew Iberia, LA$78K
Baton Rouge General Medical CenterBaton Rouge, LA$42K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.